BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33648909)

  • 1. Distribution and clinical role of KIT gene mutations in melanoma according to subtype: a study of 492 Spanish patients.
    Millán-Esteban D; García-Casado Z; Manrique-Silva E; Virós A; Kumar R; Furney S; López-Guerrero JA; Requena C; Bañuls J; Traves V; Nagore E
    Eur J Dermatol; 2021 Dec; 31(6):830-838. PubMed ID: 33648909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical significance of KIT mutations in melanoma: a meta-analysis.
    Gong HZ; Zheng HY; Li J
    Melanoma Res; 2018 Aug; 28(4):259-270. PubMed ID: 29746316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure.
    Handolias D; Salemi R; Murray W; Tan A; Liu W; Viros A; Dobrovic A; Kelly J; McArthur GA
    Pigment Cell Melanoma Res; 2010 Apr; 23(2):210-5. PubMed ID: 20088873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.
    Hodi FS; Corless CL; Giobbie-Hurder A; Fletcher JA; Zhu M; Marino-Enriquez A; Friedlander P; Gonzalez R; Weber JS; Gajewski TF; O'Day SJ; Kim KB; Lawrence D; Flaherty KT; Luke JJ; Collichio FA; Ernstoff MS; Heinrich MC; Beadling C; Zukotynski KA; Yap JT; Van den Abbeele AD; Demetri GD; Fisher DE
    J Clin Oncol; 2013 Sep; 31(26):3182-90. PubMed ID: 23775962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GAB2 amplifications refine molecular classification of melanoma.
    Chernoff KA; Bordone L; Horst B; Simon K; Twadell W; Lee K; Cohen JA; Wang S; Silvers DN; Brunner G; Celebi JT
    Clin Cancer Res; 2009 Jul; 15(13):4288-91. PubMed ID: 19509136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIT amplification and gene mutations in acral/mucosal melanoma in Korea.
    Yun J; Lee J; Jang J; Lee EJ; Jang KT; Kim JH; Kim KM
    APMIS; 2011 Jun; 119(6):330-5. PubMed ID: 21569090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale analysis of KIT aberrations in Chinese patients with melanoma.
    Kong Y; Si L; Zhu Y; Xu X; Corless CL; Flaherty KT; Li L; Li H; Sheng X; Cui C; Chi Z; Li S; Han M; Mao L; Lu A; Guo J
    Clin Cancer Res; 2011 Apr; 17(7):1684-91. PubMed ID: 21325067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIT gene mutations and copy number in melanoma subtypes.
    Beadling C; Jacobson-Dunlop E; Hodi FS; Le C; Warrick A; Patterson J; Town A; Harlow A; Cruz F; Azar S; Rubin BP; Muller S; West R; Heinrich MC; Corless CL
    Clin Cancer Res; 2008 Nov; 14(21):6821-8. PubMed ID: 18980976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low incidence of KIT gene mutations and no PDGFRA gene mutations in primary cutaneous melanoma: an immunohistochemical and molecular genetic study of Japanese cases.
    Terada T
    Int J Clin Oncol; 2010 Oct; 15(5):453-6. PubMed ID: 20425130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type.
    Torres-Cabala CA; Wang WL; Trent J; Yang D; Chen S; Galbincea J; Kim KB; Woodman S; Davies M; Plaza JA; Nash JW; Prieto VG; Lazar AJ; Ivan D
    Mod Pathol; 2009 Nov; 22(11):1446-56. PubMed ID: 19718013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences.
    Dai B; Cai X; Kong YY; Yang F; Shen XX; Wang LW; Kong JC
    Hum Pathol; 2013 Aug; 44(8):1472-8. PubMed ID: 23528861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal melanoma: clinical, histological and c-kit gene mutational profile of 86 French cases.
    Cinotti E; Chevallier J; Labeille B; Cambazard F; Thomas L; Balme B; Leccia MT; D'Incan M; Vercherin P; Douchet C; Rubegni P; Perrot JL
    J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1834-1840. PubMed ID: 28543798
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Ponti G; Manfredini M; Greco S; Pellacani G; Depenni R; Tomasi A; Maccaferri M; Cascinu S
    Anticancer Res; 2017 Dec; 37(12):7043-7048. PubMed ID: 29187493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.
    Antonescu CR; Busam KJ; Francone TD; Wong GC; Guo T; Agaram NP; Besmer P; Jungbluth A; Gimbel M; Chen CT; Veach D; Clarkson BD; Paty PB; Weiser MR
    Int J Cancer; 2007 Jul; 121(2):257-64. PubMed ID: 17372901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIT mutations in ocular melanoma: frequency and anatomic distribution.
    Wallander ML; Layfield LJ; Emerson LL; Mamalis N; Davis D; Tripp SR; Holden JA
    Mod Pathol; 2011 Aug; 24(8):1031-5. PubMed ID: 21478825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma hyperpigmentation is strongly associated with KIT alterations.
    Wu JM; Alvarez H; García P; Rojas PL; Wong G; Maitra A; Antonescu C; Montgomery EA
    Am J Dermatopathol; 2009 Oct; 31(7):619-25. PubMed ID: 19652585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607).
    Kalinsky K; Lee S; Rubin KM; Lawrence DP; Iafrarte AJ; Borger DR; Margolin KA; Leitao MM; Tarhini AA; Koon HB; Pecora AL; Jaslowski AJ; Cohen GI; Kuzel TM; Lao CD; Kirkwood JM
    Cancer; 2017 Jul; 123(14):2688-2697. PubMed ID: 28334439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumor Heterogeneity of KIT Gene Mutations in Acral Lentiginous Melanoma.
    Comodo-Navarro AN; Fernandes M; Barcelos D; Carapeto FCL; Guimarães DP; de Sousa Moraes L; Cerutti J; Iwamura ESM; Landman G
    Am J Dermatopathol; 2020 Apr; 42(4):265-271. PubMed ID: 31393283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostics of malignant melanoma of the skin : Recommendations of the current S3 guidelines on histology and molecular pathology].
    Rose C
    Pathologe; 2017 Feb; 38(1):49-61. PubMed ID: 28154916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIT in melanoma: many shades of gray.
    Slipicevic A; Herlyn M
    J Invest Dermatol; 2015 Feb; 135(2):337-338. PubMed ID: 25573046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.